Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 is displayed and an earlier government-funding status notice was removed. The study content, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice banner with links to cc.nih.gov and opm.gov. Updated the site software to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary toggle added and revision/version information updated. Minor capitalization changes to data labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter now shows Revision: v3.3.4 (replacing v3.3.3); core study content and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated the study page to revision v3.3.3 with a reorganized Locations section listing new site locations (Arkansas, California, North Carolina, Pennsylvania, Utah). The HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

- Check92 days agoChange DetectedPublications section updated to indicate that publications are automatically filled from PubMed and may not be about the study, and to reflect revision v3.3.2; the previous wording described PubMed-origin publications and referenced revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.